The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future coronavirus variants. Tested on mice, it demonstrated effectiveness against multiple Sars-CoV-2 strains. Published in ACS Nano, the research highlights the necessity for vaccines providing broad-spectrum protection amid continuous and potential future coronavirus threats.
from Times of India https://ift.tt/y9NaLVQ
https://ift.tt/BdE9WzS
The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future coronavirus variants. Tested on mice, it demonstrated effectiveness against multiple Sars-CoV-2 strains. Published in ACS Nano, the research highlights the necessity for vaccines providing broad-spectrum protection amid continuous and potential future coronavirus threats.
The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future coronavirus variants. Tested on mice, it demonstrated effectiveness against multiple Sars-CoV-2 strains. Published in ACS Nano, the research highlights the necessity for vaccines providing broad-spectrum protection amid continuous and potential future coronavirus threats.
September 12, 2024 at 08:27PM
No comments:
Post a Comment